Share

EORTC presentations at ENCR Scientific Meeting in Baveno, Italy Oct 5-7 2016

EORTC is conducting epidemiological outcome research, in partnership with population-based cancer registries in Europe, in part to evaluate real-world effectiveness of treatments tested in clinical research. As part of this, two studies will be presented as oral presentations at the European Network of Cancer Registries Scientific Meeting on October 7 under the theme ‘Cancer Registries and Clinical Data’.

The first study “Survival differences in Hodgkin lymphoma patients treated inside and outside clinical trials” will link data from six EORTC lymphoma trials and the Netherlands Cancer Registry (IKNL) to evaluate trial participation rate.

The same data is further linked with the Netherlands Patients Reported Outcome Cancer Registry (PROFILES) in the context of the second study: “Quality of life according to trial participation among Hodgkin lymphoma survivors.” Both studies are conducted in partnership with IKNL.

Back to news list

Related News

  • First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer

  • EORTC at ESMO 2026: New findings and ongoing studies

  • EORTC research presented at ESMO 2026

  • EORTC Quality of Life Group at ISOQOL 2026

  • Pink October 2026: Advancing breast cancer research, together

  • EORTC presents new results in neuro-oncology at EANO

  • In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group

  • New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults

  • New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors

  • EORTC calls for a balanced and feasible European Health Data Space (EHDS)